Incorporated in 2011, Park Medi World Limited is a private hospital chain operating primarily in North India, with a total bed capacity of 3,000 beds as of March 31, 2025.

The company operates 14 multi-super specialty hospitals under the ‘Park’ brand. All hospitals are accredited by the National Accreditation Board for Hospitals & Healthcare Providers (NABH), and eight are also accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL). The network includes facilities in Haryana, Delhi, Punjab, and Rajasthan.

Park Hospital offers more than 30 super specialty and specialty services, such as internal medicine, neurology, urology, gastroenterology, general surgery, orthopedics, and oncology.

As of Sep 30, 2025, the hospitals are equipped with 870 bedded intensive care unit (ICU) beds, 67 operating theatres (OTs), and an oxygen generation plant at each location to support critical care.

It has hospitals across several states including Haryana (Ambala, Gurugram, Karnal, Panipat, Palam Vihar, Sonipat, Faridabad), Delhi, Punjab (Patiala, Mohali), and Rajasthan (Jaipur, Behror).

As of September 30, 2025, Park Medi World Limited had a workforce of 1,014 doctors and 2,142 nurses

For the year/period ended (Rs. in Cr.)

For year/ period ended ( in Cr.)

*Market cap @upper band

• Second largest chain of private hospitals in North India and largest private hospital chain in Haryana
• Delivering high-quality and affordable healthcare with a diverse specialty mix
• Track record of successfully acquiring and integrating hospitals
• Strong operational and financial performance with diversified payor mix
• Doctor led professional management team with industry experience

The Company IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:

• Repayment/ prepayment, in full or in part, of certain outstanding borrowings availed by the Company and certain of the Subsidiaries ( Rs 380 Cr)
• Funding capital expenditure for development of new hospital and expansion of existing hospital by our certain Subsidiaries Park Medicity (NCR) and Blue Heavens, respectively (Rs 60.50 Cr)
• Funding capital expenditure for purchase of medical equipment by the Company and our certain Subsidiaries, Blue Heavens and Ratangiri (Rs 27.46 Cr)
• Unidentified inorganic acquisitions and general corporate purposes

At the upper band of IPO Rs 162 , the stock is valued at 29.21 P/E multiple. Hence, well-informed investors subscribe for medium to long term perspective.